Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Short-term Investments (2016 - 2020)

Historic Short-term Investments for Larimar Therapeutics (LRMR) over the last 7 years, with Q3 2020 value amounting to $1.0 million.

  • Larimar Therapeutics' Short-term Investments fell 9741.14% to $1.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.0 million, marking a year-over-year decrease of 9741.14%. This contributed to the annual value of $43.0 million for FY2019, which is 3736.82% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Short-term Investments of $1.0 million as of Q3 2020, which was down 9741.14% from $1.0 million recorded in Q2 2020.
  • Over the past 5 years, Larimar Therapeutics' Short-term Investments peaked at $134.7 million during Q1 2016, and registered a low of $1.0 million during Q3 2020.
  • Its 5-year average for Short-term Investments is $65.0 million, with a median of $68.2 million in 2019.
  • As far as peak fluctuations go, Larimar Therapeutics' Short-term Investments skyrocketed by 5746.33% in 2019, and later plummeted by 9814.22% in 2020.
  • Over the past 5 years, Larimar Therapeutics' Short-term Investments (Quarter) stood at $96.8 million in 2016, then tumbled by 36.73% to $61.3 million in 2017, then rose by 12.17% to $68.7 million in 2018, then plummeted by 37.37% to $43.0 million in 2019, then plummeted by 97.67% to $1.0 million in 2020.
  • Its Short-term Investments stands at $1.0 million for Q3 2020, versus $1.0 million for Q2 2020 and $24.9 million for Q1 2020.